80 related articles for article (PubMed ID: 9330665)
1. In vitro antimicrobial properties of azidothymidine (AZT).
Monno R; Marcuccio L; Valenza MA; Leone E; Bitetto C; Larocca A; Maggi P; Quarto M
Acta Microbiol Immunol Hung; 1997; 44(2):165-71. PubMed ID: 9330665
[TBL] [Abstract][Full Text] [Related]
2. The influence of the SOS response on the activity of 4-quinolones and zidovudine against some strains of Enterobacteria.
Mascellino MT; Farinelli S; Iegri F; Iona E
New Microbiol; 1998 Jan; 21(1):31-40. PubMed ID: 9497927
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance and minimum inhibitory concentrations of bacteria isolated from bustards in the United Arab Emirates.
Bailey TA; Silvanose C; Wernery U; Samour JH; Naldo J
Avian Dis; 1998; 42(4):690-7. PubMed ID: 9876837
[TBL] [Abstract][Full Text] [Related]
4. The effect of azidothymidine on germ tube formation in Candida albicans.
Monno R; Caggiano G; Coscia MF; Marcuccio L
Microbios; 2000; 103(404):53-7. PubMed ID: 11034446
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
6. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
Salmon SA; Watts JL
Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
[TBL] [Abstract][Full Text] [Related]
7. Natural resistance of human immunodeficiency virus type 2 to zidovudine.
Reid P; MacInnes H; Cong ME; Heneine W; García-Lerma JG
Virology; 2005 Jun; 336(2):251-64. PubMed ID: 15892966
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
9. The effects of azidothymidine therapy on pseudocholinesterase concentrations in asymptomatic HIV-positive patients.
Barker GM; Holland C; Katz JA
AANA J; 1994 Aug; 62(4):337-41. PubMed ID: 7810285
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
[TBL] [Abstract][Full Text] [Related]
11. [Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001)].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1035-45. PubMed ID: 12899774
[TBL] [Abstract][Full Text] [Related]
12. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
Jeeninga RE; Keulen W; Boucher C; Sanders RW; Berkhout B
Virology; 2001 May; 283(2):294-305. PubMed ID: 11336554
[TBL] [Abstract][Full Text] [Related]
13. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
15. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
16. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine.
Gao WY; Johns DG; Tanaka M; Mitsuya H
Mol Pharmacol; 1999 Mar; 55(3):535-40. PubMed ID: 10051538
[TBL] [Abstract][Full Text] [Related]
17. Isolation, molecular characterization and antimicrobial resistance patterns of Salmonella and Escherichia coli isolates from meat-based fast food in Lebanon.
Harakeh S; Yassine H; Gharios M; Barbour E; Hajjar S; El-Fadel M; Toufeili I; Tannous R
Sci Total Environ; 2005 Apr; 341(1-3):33-44. PubMed ID: 15833239
[TBL] [Abstract][Full Text] [Related]
18. Intracellular activity of zidovudine (3'-azido-3'-deoxythymidine, AZT) against Salmonella typhimurium in the macrophage cell line J774-2.
Herrmann JL; Lagrange PH
Antimicrob Agents Chemother; 1992 May; 36(5):1081-5. PubMed ID: 1510397
[TBL] [Abstract][Full Text] [Related]
19. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
